期刊
ANNALS OF NUCLEAR MEDICINE
卷 29, 期 5, 页码 442-451出版社
SPRINGER
DOI: 10.1007/s12149-015-0964-8
关键词
Positron emission tomography; Pretreatment F-18-FDG uptake; Interim PET/CT; Post-therapy PET/CT; Extranodal natural killer/T-cell lymphoma, nasal type; Prognosis
资金
- National Natural Science Foundation of China [81471693]
- Sichuan Provincial Department of science and technology support program [2012SZ0005]
Although the prognostic value of positron emission tomography/computed tomography (PET/CT) using [F-18]-fluorodeoxyglucose (F-18-FDG) has been widely confirmed for diffuse large B cell lymphoma, its value for extranodal natural killer/T-cell lymphoma, nasal type (ENKTL), is still controversial. Therefore, we designed a prospective study to investigate the prognostic value of F-18-FDG PET/CT in patients with ENKTL. Thirty-three patients with newly diagnosed, untreated ENKTL, were enrolled in this study. Interim and post-therapy PET/CT scans were analyzed by visual evaluation, in accordance with the criteria set forth by the International Harmonization Project. Patients were classified as either positive or negative. Pretreatment maximum standardized uptake values (SUVmax) of F-18-FDG were recorded in the most F-18-FDG-intense lesions. The pretreatment F-18-FDG SUV as well as the interim and post-therapy PET/CT results were assessed for the ability to predict progression-free survival (PFS) and overall survival (OS). On the pretreatment scan, the SUVmax of the indicator lesion was > 10.00 in 81.8 % of patients who were treatment-resistant and a parts per thousand currency sign10.00 in 86.4 % of patients who were treatment non-resistant (mean SUVmax, 12.93 and 8.10, respectively). Univariate analyses revealed that pretreatment SUVmax is a significant predictor (P < 0.01, P < 0.01) of PFS and OS, respectively. Multivariate analyses revealed that pretreatment SUVmax (P < 0.01, P = 0.01) and post-therapy PET/CT result (P < 0.01, P = 0.04) are independent predictors of PFS and OS, respectively. F-18-FDG uptakes prior to treatment and post-therapy PET/CT results can predict unfavorable outcomes following treatment in patients with ENKTL, but interim PET/CT results have little value in predicting survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据